Clinical Study

A Prospective, Randomized, Blinded, Placebo-Controlled, Phase IIb Trial Of An Autologous Tumor Lysate (Tl) + Yeast Cell Wall Particles (Ycwp) + Dendritic Cells (Dc) Vaccine Vs Unloaded Ycwp + Dc In Stage III And Stage Iv (Resected) Melanoma To Prevent Rec

Posted Date: Oct 25, 2017

  • Investigator: Jeffrey Sussman
  • Co-Investigator: Bridget Kinne
  • Specialties: Hematology/Oncology, Oncology, Cancer, Skin Cancer
  • Type of Study: Drug

The purpose of this study is to (1) produce and test a vaccine that is made from patient’s tumor cells and white blood cells to determine if it can prevent melanoma recurrence; (2) to look at the safety of the vaccine; and (3) to look at the immune system


To Be Eligible For This Study, Patients Must Be Being Treated For Stage Iii Or Stage Iv Melanoma That Will Be Surgically Removed (Resected) And At High Risk For Recurrence.


Elios, Cancer, Vaccine, Melanoma, Null

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.